GW501516
GW501516
Abandoned metabolic and cardiovascular drug.
No account needed. By playing, you confirm you're 13 or older and agree to the Terms of use.
No owners yet
Category: Empty
- 0 owners
- 0 copies
- 0 pulls
- Wishlisted
- 0
- In 0 albums
- On 0 showcases
- Market listings
- 0
Not sold on the market yet.
Readers' pathsAug 2026 – Oct 2026
Readers go next to
Share of the 900 clicks on its links
Peroxisome proliferator-activated receptor delta
Nuclear receptor protein found in humans.
32%
GW0742
PPAR β/δ receptor Agonist compound.
10%
Agonist
Chemical which binds to and activates a biochemical receptor.
7.8%
SR9009
Chemica compound, Agonist of Rev-ErbA.
6.1%
Sodelglitazar
Chemical compound.
5.7%
Acadesine
Chemical compound.
5.3%
Elena Lashmanova
Russian race walker.
4.9%
Ligand Pharmaceuticals
American Pharmaceutical Company.
4.6%
GLUT1
Uniporter protein.
4.3%
Nijel Amos
Botswana middle-distance runner.
2.3%
Readers come from
Share of the 2,214 readers arriving from another article
Adaejah Hodge
British Virgin Islands athlete.
46%
Kerolin
Brazilian footballer (born 1999).
11%
Nijel Amos
Botswana middle-distance runner.
4.4%
Telmisartan
Blood pressure medication.
3%
Peroxisome proliferator-activated receptor delta
Nuclear receptor protein found in humans.
2.9%
PPAR agonist
Drug used for the treatment of symptoms of metabolic syndrome.
2.8%
GW0742
PPAR β/δ receptor Agonist compound.
2.6%
Exercise mimetic
Drugs that have health benefits similar to exercise.
2.5%
SR9009
Chemica compound, Agonist of Rev-ErbA.
2.2%
Selective androgen receptor modulator
Class of pharmaceutical drugs.
1.9%